Lataa...
Tocilizumab Effects on Coagulation Factor XIII in Patients with Rheumatoid Arthritis
INTRODUCTION: Rheumatoid arthritis (RA) is a chronic systemic auto-immune disease associated with a prothrombotic state. Tocilizumab, an interleukin-6 receptor inhibitor, is highly effective in controlling disease activity and thrombotic risk. Factor XIII (FXIII), involved in thrombotic complication...
Tallennettuna:
| Julkaisussa: | Adv Ther |
|---|---|
| Päätekijät: | , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Springer Healthcare
2019
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6860466/ https://ncbi.nlm.nih.gov/pubmed/31654331 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12325-019-01118-x |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|